8TSD
Human PI3K p85alpha/p110alpha bound to RLY-2608
8TSD の概要
エントリーDOI | 10.2210/pdb8tsd/pdb |
分子名称 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform, Phosphatidylinositol 3-kinase regulatory subunit alpha, N-{(3R,6M)-3-(2-chloro-5-fluorophenyl)-6-[(4S)-5-cyano[1,2,4]triazolo[1,5-a]pyridin-6-yl]-1-oxo-2,3-dihydro-1H-isoindol-4-yl}-3-fluoro-5-(trifluoromethyl)benzamide (3 entities in total) |
機能のキーワード | lipid kinase, signaling protein, transferase-inhibitor complex, transferase/inhibitor |
由来する生物種 | Homo sapiens (human) 詳細 |
タンパク質・核酸の鎖数 | 2 |
化学式量合計 | 159798.43 |
構造登録者 | Holliday, M.,Tang, Y.,Bulku, A.,Wilbur, J.,Fraser, J. (登録日: 2023-08-11, 公開日: 2023-11-22, 最終更新日: 2024-02-21) |
主引用文献 | Varkaris, A.,Pazolli, E.,Gunaydin, H.,Wang, Q.,Pierce, L.,Boezio, A.A.,Bulku, A.,DiPietro, L.,Fridrich, C.,Frost, A.,Giordanetto, F.,Hamilton, E.P.,Harris, K.,Holliday, M.,Hunter, T.L.,Iskandar, A.,Ji, Y.,Larivee, A.,LaRochelle, J.R.,Lescarbeau, A.,Llambi, F.,Lormil, B.,Mader, M.M.,Mar, B.G.,Martin, I.,McLean, T.H.,Michelsen, K.,Pechersky, Y.,Puente-Poushnejad, E.,Raynor, K.,Rogala, D.,Samadani, R.,Schram, A.M.,Shortsleeves, K.,Swaminathan, S.,Tajmir, S.,Tan, G.,Tang, Y.,Valverde, R.,Wehrenberg, B.,Wilbur, J.,Williams, B.R.,Zeng, H.,Zhang, H.,Walters, W.P.,Wolf, B.B.,Shaw, D.E.,Bergstrom, D.A.,Watters, J.,Fraser, J.S.,Fortin, P.D.,Kipp, D.R. Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3K alpha Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia. Cancer Discov, 14:240-257, 2024 Cited by PubMed: 37916956DOI: 10.1158/2159-8290.CD-23-0944 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.7 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード